ARAN INGHAM: Open Payments
NPI 1265208185 · FLORENCE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$779 in 39 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $356 · 2025 $779
Food & beverage: $779
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $189 |
| Indivior Inc. | 5 | $180 |
| Forte Bio-Pharma LLC | 10 | $140 |
| Braeburn Inc. | 3 | $75 |
| Axsome Therapeutics, Inc. | 3 | $68 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $59 |
| Almatica Pharma LLC | 2 | $30 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
Products named: VRAYLAR, SUBLOCADE, PROLATE, BRIXADI, CAPLYTA, Sunosi, LOREEV XR, TANLOR.
Industry payments across SC — which companies pay providers there.
